Back to search

Article

Over-expression of RRM2 Predicts Poor Prognosis in Hepatocellular Carcinoma: A Bioinformatics Analysis Based on TCGA Data

2022-03-11

Abstract excerpt

<h4>Background: </h4> Ribonucleotide reductase regulatory subunit M2 (RRM2) has been reported as an oncogene in some kinds of malignant tumors, such as lung adenocarcinoma, oral squamous cell carcinoma, glioblastoma, and breast cancer. However, there are few studies focus on the clinical significance of RRM2 in Hepatocellular Carcinoma. This work aimed to evaluate the significance of RRM2 in Hepatocellular carcino...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b6036a26-c1f1-5d0d-9385-d3b03856176d
DOI
10.21203/rs.3.rs-1395238/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Over-expression of RRM2 Predicts Poor Prognosis in Hepatocellular Carcinoma: A Bioinformatics Analysis Based on TCGA DataDOI 10.21203/rs.3.rs-1395238/v1
Select a neighboring publication to make it the new centre.